February 20, 2013Open Access

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

SRSuman RijalWorld Health Organization Regional Office for South-East Asia BOBart OstynInstituut voor Tropische Geneeskunde SUSurendra UranwB.P. Koirala Institute of Health Sciences

Key Points

Key points are not available for this paper at this time.

Abstract

Relapse in one-fifth of the MIL-treated patients observed in our study is an alarming signal for the VL elimination campaign, urging for further review and cohort monitoring.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Rijal et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9a0e89a6164e50fa3d21c https://doi.org/https://doi.org/10.1093/cid/cit102

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper